Jefferson University Hospitals

Provider Profile

Joanne E. Filicko-O'Hara, MD

Joanne E. Filicko-O'Hara, MD

Jefferson University Physician

Academic Title: Associate Professor
Program Director, Combined Fellowship in Hematology/Medical Oncology

Specialties
Hematology - Medical Oncology
Medical Oncology
Medical Oncology - Bone Marrow Transplant
Medical Oncology - Hematologic Malignancies
Medical Oncology - Leukemia/Lymphoma

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
925 Chestnut Street
Suite 420A
Philadelphia PA 19107
Phone: (215) 955-8874
Fax: (215) 955-2340

Medical Services

Years in Practice

20

Board Certifications

  • Hematology
  • Medical Oncology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Awards and Honors

Jefferson Medical College: American Medical Women's Association Faculty Award 2011

Leukemia and Lymphoma Society Service to Mankind Award 2009

Attending Teaching Award, Department of Medicine, TJUH 2008

Golden Apple Teaching Award, Department of Medicine, TJUH 2007

Castle Connolly Top Doctor - Hematology 2011,2012,2013,2014,2015,2016,2017

Castle Connolly- America's Top Doctors for Cancer 2010,2011,2012,2013,2014,2015,2016,2017

Castle Connolly Exceptional Women in Medicine 2017

Notes

Also specializes in Myeloproliferative Disorders, Multiple Myeloma and Stem Cell Transplantation for Non-Malignant Diseases such as Sickle Cell Anemia and Autoimmune Diseases.

Personal Statement

I believe that the best medical care is provided when patients and care teams communicate well. We should help our patients to become well informed about the diseases we're treating and the treatments we offer. We should work together to provide the best outcomes, with the least amount of side effects. As therapies for cancer and blood diseases become more personalized, care of individual patients becomes more individualized as well.

Education

  • Hahnemann University School of Medicine, Medical School

Internship

  • Thomas Jefferson University Hospital

Residency

  • Thomas Jefferson University Hospital

Fellowship

  • Thomas Jefferson University Hospital

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna
  • Aetna PA Employee Benefit Trust Fund (PEBTF)
  • AmeriHealth
  • Amerihealth Caritas
  • AmeriHealth Comprehensive
  • AmeriHealth HMO
  • AmeriHealth Major Medical
  • AmeriHealth Personal Choice
  • Blue Choice
  • Blue Cross/Blue Shield
  • Cigna Healthspring
  • Consumer Health Network PPO
  • CorVel
  • Coventry/Health America
  • Devon
  • Employers Health Network PPO
  • Evolutions (Guardian Resources)
  • Federal BCBS
  • Galaxy
  • Geisinger Health Plan
  • Health America PPO
  • Health Management Network PPO
  • Horizon Blue Cross/Blue Shield
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Inter-County Health Plan
  • Intergroup Preferred
  • Jeff Plus
  • Keystone 65 HMO
  • Keystone First VIP Choice
  • Keystone First/Connect
  • Keystone Health Plan East
  • Medicaid of New Jersey
  • Medicaid of PA
  • Medicare
  • Mercy LIFE
  • MultiPlan Inc.
  • NJ Blue Shield
  • Personal Choice (GPPPN)
  • Personal Choice 65
  • PlanCare America
  • PPO Next
  • Preferred Care PPO
  • Premier Blue
  • Prime Health Services, Inc.
  • Qualcare
  • Tricare
  • UPMC HMO,PPO ReadingHspEmpONLY
  • UPMC Medicare HMO
  • US Family Health Plan

Recent Publications

Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell Transplantation

Chronic lymphocytic leukemia/small lymphocytic lymphoma with pancytopenia and chylothorax

Testicular lymphoma

Antiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease

Adenovirus DNA polymerase is recognized by human CD8+T cells

Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vβ use: A new paradigm for designer allogeneic blood and marrow transplantation

T Cell Repertoire Complexity Is Conserved after LLME Treatment of Donor Lymphocyte Infusions

Treatment of Adenovirus Disease in Stem Cell Transplant Recipients with Cidofovir

Heterogeneous clearance of antithymocyte globulin after CD34+ -selected allogeneic hematopoietic progenitor cell transplantation

Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: A phase I study

Activity of single-agent melphalan 220-300 mg/m2with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma

Cytoprotection in acute myelogenous leukemia (AML) therapy

Sensorineural hearing loss associated with intrathecal vancomycin

Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: New approaches to prophylaxis and treatment

Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches

Linezolid in the treatment of vancomycin resistant enterococcus infections in allogeneic stem cell transplant patients